Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions

Chronic Iron Overload

Interventions

OTHER

Physician survey

Survey to assess physicians' knowledge of Exjade posology and biological monitoring recommendations as described in the Educational Materials

Trial Locations (1)

Novartis Investigative Site, Basel